AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Rhea-AI Summary
AbbVie (NYSE: ABBV) has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference scheduled for Tuesday, September 9, 2025. The company's management will engage in a fireside chat presentation at 9:00 a.m. Central time.
Investors can access the presentation through a live audio webcast on AbbVie's Investor Relations website at investors.abbvie.com. An archived version of the session will be made available later the same day.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, ABBV gained 0.72%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Media: Gabby Tarbert | Investors: Liz Shea |
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-morgan-stanley-23rd-annual-global-healthcare-conference-302542190.html
SOURCE AbbVie
